Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia between 34 and 37 weeks' gestation (HYPITAT-II): a multicentre, open-label randomised controlled trial

BACKGROUND: Gestational hypertension (GH) and pre-eclampsia (PE) can result in severe complications such as eclampsia, placental abruption, syndrome of Hemolysis, Elevated Liver enzymes and Low Platelets (HELLP) and ultimately even neonatal or maternal death. We recently showed that in women with GH...

Descripción completa

Detalles Bibliográficos
Autores principales: Langenveld, Josje, Broekhuijsen, Kim, van Baaren, Gert-Jan, van Pampus, Maria G, van Kaam, Anton H, Groen, Henk, Porath, Martina, Oudijk, Martijn A, Bloemenkamp, Kitty W, Groot, Christianne J de, van Beek, Erik, van Huizen, Marloes E, Oosterbaan, Herman P, Willekes, Christine, Wijnen-Duvekot, Ella J, Franssen, Maureen T M, Perquin, Denise A M, Sporken, Jan M J, Woiski, Mallory D, Bremer, Henk A, Papatsonis, Dimitri N M, Brons, Jozien T J, Kaplan, Mesruwe, Nij Bijvanck, Bas W A, Mol, Ben-Willen J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161905/
https://www.ncbi.nlm.nih.gov/pubmed/21736705
http://dx.doi.org/10.1186/1471-2393-11-50

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161905/
https://www.ncbi.nlm.nih.gov/pubmed/21736705
http://dx.doi.org/10.1186/1471-2393-11-50

Ejemplares similares